Viveve Medical (VIVE) Misses Q2 EPS by 18c

Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.66), $0.18 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Lennar (LEN) PT Lowered to $108 at Argus